Humana (HUM) shares are down about 4% to $215.30 in morning trading after Bloomberg reported that the company lost its lawsuit seeking to reverse cuts to its Medicare bonus payments. A Texas district court ruled in favor of the government’s motion to dismiss the case, affirming the Medicare program’s downgrade of Humana’s quality ratings and dealing a blow for the insurer, which hoped the court would restore billions in revenue, according to Bloomberg’s report.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana loses in suit to reverse Medicare bonus payment cut, Bloomberg reports
- ACA marketplace plans seek double digit rate increases for 2026, WSJ says
- U.S. Health insurers prescription drug denials on the rise, NYT says
- Humana price target lowered to $260 from $280 at Truist
- Trump Trade: U.S. slaps 30% tariff rate on EU, Mexico